Dr. Tong Sun, MD

Dr. Sun practices at U.S. Renal Care Parkway Dialysis in Modesto, California.

Dr. Sun's NPI, 1629161336, was assigned on October 2, 2006. Dr. Sun graduated from Shanghai Medical University in 1991. Dr. Sun holds California license A97313.

Dr. Sun's primary practice is U.S. Renal Care Parkway Dialysis, at 2200 Plaza Parkway, Suite B1-B4, Modesto, CA 95350 in Stanislaus County. The practice phone is (209) 574-6818.

Dr. Sun's primary practice is U.S. Renal Care Parkway Dialysis in Modesto, California. Dr. Sun is also affiliated with Memorial Medical Center. The medical group on file is Modesto Kidney Medical Group. Dmand AI also links Dr. Sun to 4 more hospitals, 4 dialysis centers and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sun practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sun's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Sun is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Sun's licenses on file in 3 states: California, Florida and New York.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney cysts among the conditions Dr. Sun treats.

CMS data shows 3,469 Medicare services from Dr. Sun across 11 procedure codes in 2024, for 662 Medicare patients. Medicare paid $362,733 for them.

CMS counts 662 Medicare patients who saw Dr. Sun in 2024. The largest group is 75 to 84, with 238 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 56% are also on Medicaid. Their average risk score is 3.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sun's median patient age at 74, with 50% women.

In 2024, Dr. Sun wrote 6,711 Medicare Part D claims for 725 patients. 86% of them were for generic drugs. CMS names the drug for 6,424 of them, across 57 drugs with 11 or more claims each, at $365,211 in total drug cost. In 2023, CMS named 6,080 claims across 62 drugs.

Dr. Sun accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sun as offering telehealth.

Dmand AI links 10 papers to Dr. Sun, published from 2009 to 2016. 2010 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Genetic Predisposition to Disease and Polymorphism, Single Nucleotide. Dr. Sun has published most often in Clin Cancer Res. Dr. Sun's most frequent co-authors are Philip W. Kantoff, MD, William K. Oh, MD and William Oh, MD.

CMS Open Payments shows 213 general payments to Dr. Sun from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. AstraZeneca Pharmaceuticals LP paid the most, $892.

Dmand AI lists 1 award for Dr. Sun, most recently CMS Stage 1 EHR in 2013.

Dr. Sun graduated from Shanghai Medical University in 1991.

Dr. Sun is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.